Stock Market

Home > Markets-Economic Times > Maintain buy on Aurobindo Pharma, lower target price to Rs 530: Analyst

Maintain buy on Aurobindo Pharma, lower target price to Rs 530: Analyst

March 12, 2020
A strong ANDA pipeline, potential synergy benefit post closure of Sandoz acquisition and operating leverage for EU business are reasons for the positive stance on Aurobindo Pharma.

from Markets-Economic Times https://ift.tt/3cQQlql

Post a Comment

No comments

Subscribe to: Post Comments ( Atom )
Powered by Blogger.